Shifting the disease management paradigm from glucose: what are the cons?
Hanefeld
Markolf
M
Center for Clinical Studies Dresden, Dresden, Germany. hanefeld@gwtonline-zks.de
Bornstein
Stefan R
SR
Pistrosch
Frank
F
D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood* / Q000453:epidemiology / Q000401:mortality; D048909:Diabetes Complications / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000097:blood*; D003925:Diabetic Angiopathies / Q000097:blood* / Q000453:epidemiology / Q000401:mortality; D005215:Fasting; D005260:Female; D006801:Humans; D050417:Insulin-Secreting Cells / Q000502:physiology; D008297:Male; D009765:Obesity / Q000517:prevention & control; D012307:Risk Factors; D012727:Sex Characteristics; D015430:Weight Gain
D015415:Biomarkers; D001786:Blood Glucose